CymitQuimica logo
MAPK

MAPK

MAPKs are a family of protein kinases involved in a variety of cellular processes, including growth, proliferation, differentiation, and stress responses. The MAPK signaling pathway consists of several tiers, including ERK, JNK, and p38 MAPKs, each playing distinct roles in cellular function. Dysregulation of MAPK signaling is linked to cancer, inflammatory diseases, and metabolic disorders. At CymitQuimica, we offer a wide array of MAPK inhibitors and activators to support your research in cell biology, signal transduction, and disease mechanisms.

Found 924 products for "MAPK".

products per page.
  • CST905

    CAS:
    CST905 is an efficient PROTAC BRAF-V600E degrader with a DC50 of 18 nM, suitable for cancer research.
    Formula:C51H58F2N10O7S2
    Molecular weight:1025.20
  • KRAS G12C inhibitor 18

    CAS:
    KRAS G12C inhibitor 18 is a potent, orally active compound that inhibits KRAS G12C and exhibits anti-tumor activities.
    Formula:C25H20ClFN4O3S
    Color and Shape:Solid
    Molecular weight:510.97
  • Endothelin-1 (1-31) (Human)

    CAS:
    Endothelin-1 (1-31) is a human-derived vasoconstrictor and hypertensive formed by chymase hydrolysis of big ET-1.
    Formula:C162H236N38O47S5
    Molecular weight:3628.16
  • BI1701963


    BI1701963 is an orally effective inhibitor that targets the SOS1 and KRAS interaction, specifically inhibiting the activation of KRAS by blocking its GTP loading. This compound is utilized in cancer research to explore potential therapeutic effects against KRAS-driven malignancies.
    Formula:C47H62N8O4S
    Color and Shape:Solid
    Molecular weight:835.11
  • MS432


    MS432 is a highly selective PD0325901-based VHL-recruiting PROTAC degrader for MEK1 and MEK2.
    Formula:C50H65F3IN7O6S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:1076.06
  • KRASG12C IN-14


    KRASG12C IN-14 (compound 15), a potent inhibitor specifically designed for the KRAS G12C mutation, exhibits impressive efficacy in impeding CYPA-dependent KRAS-BRAF interaction and ERK phosphorylation in NCI-H358 cells, both with an IC 50 of 0.002 μM.
    Formula:C51H65F4N9O9S2
    Color and Shape:Solid
    Molecular weight:1088.24
  • JNK3 inhibitor-8


    JNK3 inhibitor-8: potent, selective, oral, BBB-penetrating, IC50: JNK3=21 nM, JNK2=2203 nM, JNK1>10,000 nM; potential in Alzheimer's research.
    Formula:C32H30FN7O3
    Color and Shape:Solid
    Molecular weight:579.62
  • PROTAC MLKL Degrader-1


    PROTAC MLKL Degrader-1 (Compound 36) is a selective PROTAC degrader targeting MLKL, achieving a degradation maximum (D max) over 90%.
    Formula:C46H55F2N9O9S
    Color and Shape:Solid
    Molecular weight:948.05
  • NecroX-2

    CAS:
    NecroX-2 is a cell-permeable necrosis inhibitor with antioxidant properties. NecroX-2 selectively suppresses necrotic cell death triggered by oxidative stress. NecroX-2 does not confer protection against apoptosis induced by staurosporine or etoposide but shows protective effects under conditions such as cold shock, hypoxia, and oxidative stress in vitro.
    Formula:C25H32N4O4S2
    Purity:97.12%
    Color and Shape:Solid
    Molecular weight:516.68
  • AM-001

    CAS:
    AM-001 is a non-competitive Epac1 inhibitor that blocks Rap1 activation and is used in heart disease research.
    Formula:C24H16FN3OS2
    Purity:99.92%
    Color and Shape:Yellow Solid
    Molecular weight:445.532
  • Anticancer agent 207


    Anticanceragent 207 (compound 10b) is an effective anticancer agent. It binds to NRAS rG4 with a KD value of 2.31 µM. It exhibits cytotoxicity and reduces NRAS protein expression, demonstrating antitumor activity.
    Formula:C29H39FN4O2
    Molecular weight:494.3057
  • SOS1-IN-24


    SOS1-IN-24 (Compound 15) is an SOS1 inhibitor with an IC50 of 0.398 μM, effectively blocking the interaction of SOS1::KRAS12D. It is applicable in research on cancers such as pancreatic and colorectal cancer.
  • RTIL 13

    CAS:
    RTIL 13 inhibits dynamin GTPase (IC50: 2.3 μM), targets its lipid binding domain, and suppresses endocytosis (IC50: 9.3 & 7.1 μM).
    Formula:C30H55BrN2O3
    Color and Shape:Solid
    Molecular weight:571.685
  • JNK-IN-15, Cell-Permeable, Negative Control


    JNK-IN-15, Cell-Permeable, Negative Control serves as the negative control for JNK-IN-15, Cell-Permeable. JNK-IN-15, Cell-Permeable functions as an inhibitor of JNK.
    Formula:C191H336N70O48S
    Color and Shape:Solid
    Molecular weight:4410.57236
  • SMU-L11


    SMU-L11 is a specific TLR7 agonist (EC50=0.024 μM) that recruits the MyD88 adaptor protein, activating downstream NF-κB and MAPK signaling pathways. In mouse models, SMU-L11 significantly enhances immune cell activation and boosts CD4+ T and CD8+ T cell proliferation, leading to direct tumor cell destruction and inhibition of tumor growth. This compound has applications in cancer research and potential in studying immune system disorders.
    Formula:C19H24N4O
    Molecular weight:324.19501
  • ADT-007

    CAS:
    ADT-007 is a pan-RAS inhibitor with potent anticancer activity.
    Formula:C26H24FNO5
    Purity:98.82%
    Color and Shape:Yellow Solid
    Molecular weight:449.47
  • L-JNKI-1


    L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK, it has been shown to effectively inhibit JNK activity in in vivo studies.
    Formula:C164H286N66O40
    Purity:98%
    Color and Shape:Solid
    Molecular weight:3822.44
  • FAM49B (190-198) mouse

    CAS:
    FAM49B (190-198) mouse represents a peptide fragment of the mitochondria-localized protein FAM49B, which is instrumental in regulating mitochondrial fission, function, and integrity, in addition to influencing tumor progression. Beyond its role in mitochondrial dynamics, FAM49B serves as a negative regulator of T cell activation by inhibiting GTPase Rac activity and affecting cytoskeleton reorganization.
    Formula:C49H71N9O14S
    Color and Shape:Solid
    Molecular weight:1042.2
  • PPARγ agonist-21


    PPARγagonist-21 (Compound 9a) is a PPARγ agonist with an EC50 of 3.12 μM. It inhibits NF-κB by activating PPAR-γ and reduces the assembly of the NLRP3 inflammasome. PPARγagonist-21 blocks interactions between NLRP3-ASC and NLRP3-NEK7, alleviating the severity of gouty arthritis.
  • (S,R,S)-AHPC-Me-C10-Br

    CAS:
    (S,R,S)-AHPC-Me-C10-Br is a chemically synthesized conjugate and ligand-linker for E3 ligase, MS432 for MEK1/2 inhibitors and a VHL E3 ligase linker.
    Formula:C34H51BrN4O4S
    Purity:98.89%
    Color and Shape:Solid
    Molecular weight:691.762